Skip to main content

Posts

Showing posts with the label metapneumovirus

Shifting tides: increased #severity despite fewer visits for #infant respiratory #infections across two consecutive post-pandemic winters in Northern #Italy

  Abstract This study compares infant (0–24 months) respiratory infection presentations to a Northern Italian paediatric emergency department across two post-pandemic winters ( 2022–2023 vs 2023–2024 ). Despite an approximate 44% reduction in visits in 2023–2024 (N=176 in 2023–2024 vs N=317 in 2022–2023), infants in the 2023–2024 season experienced significantly higher proportions of ventilatory support (51.1% vs 32.8%, p<0.001) and intensive care unit admission (15.9% vs 1.9%, p<0.001) than those presenting in 2022–2023, with a non-significant trend towards higher hospitalisation (88.1% vs 81.7%, p=0.052). Respiratory syncytial virus re-emerged as the dominant pathogen (43.2% vs 27.7%, p<0.001) in 2023–2024, alongside increased human metapneumovirus and influenza A H1N1 . These findings highlight a concerning shift towards increased severity, underscoring the need for ongoing surveillance. Source: BMJ Paediatric Open,  https://bmjpaedsopen.bmj.com/content/9/1/e003695...

Resurgence of #human #metapneumovirus in the post #COVID19 era: #pathogenesis, epidemiological shifts, clinical #impact, and future #challenges

Summary Human metapneumovirus (hMPV), a respiratory pathogen identified in 2001, is a substantial cause of community-acquired respiratory infections across all age groups. This Review explores the impact of hMPV after the COVID-19 pandemic , emphasising its resurgence as a public health concern . Epidemiological shifts, as well as unusual seasonal patterns , increased co-infection rates, and altered age distributions, have been observed globally. Phylogenetic analysis has shown the variation across three distinct periods , especially before and after the COVID-19 pandemic, in terms of genotypic distribution. Clinical manifestations of hMPV infection range from asymptomatic to severe lower respiratory tract infections , particularly in vulnerable populations. Specific antivirals or vaccines are currently unavailable; consequently, treatment remains supportive. The development of monoclonal antibodies and vaccines leveraging cross-protective strategies against hMPV and related viruses is...

#HK CHP investigates severe #paediatric case of #COVID19 co-infected with human #metapneumovirus

{Excerpt} The Centre for Health Protection (CHP) of the Department of Health today (April 23) received a report of a case of severe paediatric COVID-19 and human metapneumovirus (hMPV) infection and reminded the public to observe personal, hand and environmental hygiene at all times. High-risk individuals should receive a COVID-19 vaccination as soon as possible and receive booster doses at appropriate times to minimise the risk of serious complications and death after infection. The case involves an eight-month-old girl with good past health, who developed a fever and runny nose since April 19 and sought medical attention from a private doctor the next day. She developed cough and shortness of breath on April 21 and sought medical attention from another private doctor. She attended the Accident and Emergency Department of Hong Kong Adventist Hospital – Tsuen Wan on April 22 and was transferred to the Paediatric Intensive Care Unit of Princess Margaret Hospital for treatment on the sam...

#Trends of acute respiratory #infection, including human #metapneumovirus, in the Northern Hemisphere

Situation at a glance In many countries of the Northern Hemisphere , trends in acute respiratory infections increase at this time of year.  These increases are typically caused by seasonal epidemics of respiratory pathogens such as seasonal influenza, respiratory syncytial virus (RSV), and other common respiratory viruses , including human metapneumovirus (hMPV), as well as mycoplasma pneumoniae .  Many countries conduct routine surveillance for acute respiratory infections and common respiratory pathogens.  Currently, in some countries in the temperate Northern hemisphere, influenza-like illness (ILI) and/or acute respiratory infection (ARI) rates have increased in recent weeks and are above baseline levels, following usual seasonal trends.  Seasonal influenza activity is elevated in many countries in the Northern hemisphere.  Where surveillance data is available , trends in RSV detections currently vary by region with decreases reported in most regions except ...

#Avian #flu #risk still ‘low’ after first #US #patient dies from #H5N1 virus: #WHO

7 January 2025  A day after the United States reported its first human death from avian flu, the UN World Health Organization (WHO) insisted on Tuesday that the risk to the wider population remains “low”.  WHO spokesperson Dr. Margaret Harris told reporters in Geneva that the H5N1 virus causing the disease is “ not circulating in humans but jumping into humans ” who are exposed to poultry or dairy cattle. “ We’re not seeing sustained circulation ,” she insisted. Underlying conditions The man who died of the disease in Louisiana was over 65 and reportedly had underlying medical conditions, Dr. Harris said.  According to the health authorities , he had been exposed to chickens and wild birds . Several dozen people in the US have contracted avian influenza – commonly referred to as bird flu – during the current outbreak, mainly farmworkers in close contact with poultry flocks and cattle herds. Dr. Harris stressed that WHO’s assessment of the risk to the general population “i...

#China, National sentinel #surveillance of acute #respiratory infectious #diseases (Week 52, 2024)

{Excerpt} In the 52nd week of 2024 ( December 23rd to December 29th ), respiratory samples from outpatient influenza-like cases and hospitalized severe acute respiratory infection cases collected in sentinel hospitals across the country (excluding Hong Kong, Macao and Taiwan) were tested for 10 viruses including the new coronavirus, influenza virus, respiratory syncytial virus, adenovirus, human metapneumovirus, parainfluenza virus, common coronavirus, bocavirus, rhinovirus and enterovirus , as well as multiple respiratory pathogens including Mycoplasma pneumoniae. 1. Test results The pathogens detected positive in respiratory samples of influenza-like cases in outpatient and emergency departments of sentinel hospitals were mainly influenza virus, human metapneumovirus, and rhinovirus ; the pathogens detected positive in respiratory samples of hospitalized severe acute respiratory infection cases were mainly influenza virus, Mycoplasma pneumoniae, and human metapneumovirus . The specif...